4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-011636
Director sold 18,167 shares at $12.12 ($220,246)
From the SEC's structured data for this filing
Trades in this filing
Kauffman Michael · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-17 | Sale : show line 1 in the form | −9,079 | $12.12 | $110,068 | 698,983 | D |
| 2022-02-17 | Sale : show line 2 in the form | −9,088 | $12.12 | $110,177 | 904,357 | I |
| Open-market sales · 18,167 sh · avg $12.12 · $220,246 | ||||||
Loading xslF345X03/doc4.xml…